Views: 0 Author: Site Editor Publish Time: 2022-08-18 Origin: Site
The world's first picosecond aesthetic laser-optimal wavelengths for treating pigmentary conditions and overall skin revitalization, with the added capability of tattoo removal.
Cynosure’s PicoSure laser treats at three wavelengths: 532nm, 755nm, and 1064 nm, making it ideal for treatment of pigmentary conditions. With the addition of the Focus™ Lens Array, you’ll be able to treat stubborn skin conditions in addition to removing tattoos.
Creating an intense photothermal impact in trillionths of a second, PicoSure’s advanced technology spares the skin high thermal damage and targets the chromophore for better clearance in fewer treatments.
· Optimally targets melanin to treat a range of pigmentary conditions
· Incurs minimal thermal damage due to picosecond pulse duration
· Customizable treatments with 2-6mm, 8mm, and 10mm spot sizes
· Proven clinical validation, with 26 publications and 59 abstracts to date
PicoSure makes tattoo removal even easier. The 755nm wavelength is able to target black, blue, and green tattoo inks, while the optional 532nm wavelength offers effective treatment of “sunset colors”—red, yellow and orange—which are typically hard to correct. You’ll also be able to:
· Tailor treatments using variable spot sizes
· Use boost mode to better treat recalcitrant tattoos with shortened pulse width
· Treat black ink in darker skin type patients using the 1064nm delivery
Cynosure’s Focus Lens Array creates microscopic, photomechanical reactions in the epidermis that communicate with the dermis, leading to increased collagen and elastin in the skin. This breakthrough enables skin revitalization with virtually no downtime—only with our PicoSure laser.
“All of my fractional ablative patients who have transitioned to the PicoSure using the FOCUS lens array report reduced discomfort and minimal downtime compared to their prior treatments. Overall I have been especially impressed with how minimal and brief the duration of redness is after treatment compared to my other fractional lasers.”
David McDaniel, MD